Today's Low
₹ 98.80
Today's High
₹ 99.05
52 Weeks Low
₹ 57.90
52 Weeks High
₹ 143.45
Lower
₹ 96.85
Upper
₹ 100.75
Brooks Laboratories Limited manufactures and sells pharmaceuticals on contract basis in India and internationally. It offers carbapenem drugs; tablets; dry syrup; liquid and dry power injections; and eye and ear drop. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2022 | FY 2021 |
---|---|---|
Total Current Assets | 61.2 | 47.4 |
Total Non-Current Assets | 133.4 | 112.2 |
Total Assets | 194.6 | 162.1 |
Total Current Liabilities | 48.9 | 63.6 |
Total Non-Current Liabilities | 11.4 | 19.3 |
Shareholder's Funds | 63.1 | 79.2 |
Total Liabilities | 194.6 | 162.1 |
The Industry Price to BV stands at 6.02, vs the Price to BV of 3.25, which results in a Negative aspect.
The Industry Current Ratio stands at 2.39, vs the Current Ratio of 0.74, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.19, vs the Debt to Equity Ratio of 0.40, which results in a Negative aspect.
The Industry Quick Ratio stands at 1.65, vs the Quick Ratio of 0.37, which results in a Negative aspect.
Particulars | FY 2022 | FY 2021 |
---|---|---|
Total Income | 91.1 | 77.3 |
Total Expenditure | 105.4 | 76.7 |
Operating Profit(Excl OI) | -13.5 | 1.3 |
Add: Other Income | 0.9 | 0.7 |
Operating Profit | -13.5 | 1.3 |
Less: Interest | 3.1 | 3.1 |
PBDT | -16.6 | -1.8 |
Less: Depreciation Amortization | 7.4 | 7.1 |
PBT & Exceptional Items | -23.9 | -9.0 |
Less: Exceptional Income Expenses | 0.0 | 0.0 |
Profit Before Tax | -23.9 | -9.0 |
Less: Taxation | -4.6 | 10.4 |
Profit After Tax | -19.3 | -19.4 |
Earnings Per Share | -0.1 | -0.1 |
The Industry PAT Margin stands at 9.80, vs the PAT Margin of -25.08, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.60, vs the Dividend Yield of 0.00, which results in a Negative aspect.
The Industry PAT Growth stands at 37.09, vs the PAT Growth of 0.00, which results in a Negative aspect.
The Industry PE Ratio stands at 42.42, vs the PE Ratio of 0.00, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|
Profit Before Tax | -35.4 | -23.9 | -9.0 |
Tax Paid | -0.2 | -0.3 | -4.2 |
Adjustment | 9.7 | 11.0 | 10.3 |
Changes In Working Capital | -35.4 | -23.9 | -9.0 |
Cash Flow after changes in Working Capital | -14.3 | -37.2 | 8.7 |
Cash Flow from Operating Activities | -14.5 | -37.4 | 4.5 |
Cash Flow from Investing Activities | 0.5 | -24.9 | -5.1 |
Cash Flow from Financing Activities | 11.4 | 64.1 | 1.2 |
Net Cash Inflow / Outflow | -2.6 | 1.7 | 0.5 |
Opening Cash & Cash Equivalents | 2.6 | 0.9 | 0.4 |
Closing Cash & Cash Equivalent | 0.0 | 2.6 | 0.9 |
The Industry PFCF Ratio stands at 21.25, vs the PFCF Ratio of -14.65, which results in a Negative aspect.
The Industry PCF RATIO stands at 26.76, vs the PCF RATIO of 34.43, which results in a Positive aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 217.5 | 243.2 | 157.0 | 126.1 | 153.0 | 180.8 | 171.2 | 284.6 | 190.1 | 210.1 | 217.0 | 146.2 | 209.2 | 292.4 |
Total Income | 219.0 | 244.1 | 157.6 | 126.3 | 154.0 | 182.2 | 171.6 | 286.5 | 193.8 | 215.7 | 224.0 | 146.8 | 209.6 | 297.7 |
Total Expenditure | 206.5 | 226.0 | 156.8 | 127.3 | 238.6 | 273.1 | 257.2 | 323.7 | 253.9 | 256.1 | 220.7 | 185.4 | 215.8 | 238.9 |
PBIDT (Excl OI) | 11.0 | 17.2 | 0.3 | -1.2 | -85.5 | -92.3 | -86.0 | -39.1 | -63.8 | -46.0 | -3.7 | -39.3 | -6.6 | 53.5 |
Other Income | 1.6 | 0.9 | 0.6 | 0.2 | 0.9 | 1.4 | 0.3 | 1.8 | 3.7 | 5.6 | 7.0 | 0.6 | 0.4 | 5.2 |
Operating Profit | 12.5 | 18.1 | 0.8 | -1.0 | -84.6 | -90.9 | -85.7 | -37.3 | -60.1 | -40.4 | 3.3 | -38.7 | -6.2 | 58.8 |
Interest | 2.1 | 1.9 | 1.7 | 1.8 | 7.5 | 6.3 | 6.2 | 8.4 | 7.4 | 7.5 | 7.6 | 7.4 | 7.8 | 8.0 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 3.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 10.4 | 16.2 | -0.9 | -2.9 | -88.5 | -97.2 | -91.9 | -45.7 | -67.6 | -47.9 | -4.3 | -46.1 | -14.0 | 50.7 |
Depreciation | 4.4 | 4.4 | 4.4 | 4.4 | 23.3 | 22.8 | 19.8 | 19.5 | 18.8 | 17.4 | 17.8 | 17.4 | 17.2 | 17.1 |
Profit Before Tax | 6.0 | 11.8 | -5.3 | -7.2 | -111.8 | -120.0 | -111.7 | -65.2 | -86.4 | -65.3 | -22.1 | -63.5 | -31.2 | 33.7 |
Tax | 0.3 | 0.0 | 0.0 | 0.0 | -17.0 | -38.6 | -17.7 | -5.8 | -12.3 | -18.3 | -9.4 | 103.8 | 0.0 | 0.0 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 5.8 | 11.8 | -5.3 | -7.2 | -94.8 | -81.4 | -94.0 | -59.4 | -74.1 | -47.0 | -12.7 | -167.3 | -31.2 | 33.7 |
Net Profit | 5.8 | 11.8 | -5.3 | -7.2 | -94.8 | -81.4 | -94.0 | -59.4 | -74.1 | -47.0 | -12.7 | -167.3 | -31.2 | 33.7 |
ADDITIONAL INFOS: | ||||||||||||||
Equity Capital | 262.5 | 262.5 | 247.0 | 247.0 | 247.0 | 247.0 | 247.0 | 247.0 | 247.0 | 247.0 | 247.0 | 247.0 | 247.0 | 247.0 |
Reserves | 492.5 | 492.5 | 492.5 | 627.9 | 627.9 | 627.9 | 383.5 | 544.5 | 544.5 | 544.5 | 544.5 | 0.0 | 0.0 | 0.0 |
EPS | -1.5 | -0.6 | -1.8 | -1.7 | -2.0 | -3.2 | -3.8 | -1.5 | -3.1 | -2.0 | -0.5 | -6.9 | -1.0 | 1.4 |
Operating Profit Margin | 5.8 | 7.4 | 0.5 | -0.8 | -55.3 | -50.3 | -50.0 | -13.1 | -31.6 | -19.2 | 1.5 | -26.5 | -3.0 | 20.1 |
Net Profit Margin | 2.7 | 4.9 | -3.4 | -5.7 | -62.0 | -45.0 | -54.9 | -20.9 | -39.0 | -22.4 | -5.8 | -114.5 | -14.9 | 11.5 |
The Industry Mcap Growth stands at 29.96, vs the Mcap Growth of 0.00, which results in a Negative aspect.
The Industry Net Sales Growth stands at 10.79, vs the Net Sales Growth of 0.00, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 99.30 | 99.61 | 98.94 |
R3 | 99.22 | 99.18 | 98.87 |
R2 | 99.13 | 99.11 | 98.85 |
R1 | 98.97 | 98.93 | 98.82 |
Pivot | 98.88 | 98.86 | 98.88 |
S1 | 98.72 | 98.68 | 98.78 |
S2 | 98.63 | 98.61 | 98.75 |
S3 | 98.47 | 98.43 | 98.73 |
S4 | 98.30 | 98.11 | 98.66 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
45.65
Neutral
RSI
35.14
Neutral
ROC
-3.70
Bearish
UltimateOscillator
20.07
Bearish
Williams Indicator
-71.67
Neutral
CCI Indicator
-65.64
Neutral
MACD
-2,844.54
Bearish
Stochastic Indicator
30.00
Neutral
ATR
4.76
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|
Date Of Conduct | Board Meeting Details |
---|---|
31-01-2024 | Quarterly Results |
24-01-2024 | Issue Of Warrants & Preferential Issue of shares & Rights Issue |
09-11-2023 | Quarterly Results |
10-08-2023 | Quarterly Results |
18-07-2023 | Right Issue of Equity Shares |
11-07-2023 | Right Issue of Equity Shares |
29-05-2023 | Audited Results |
14-02-2023 | Quarterly Results |
25-01-2023 | Right Issue of Equity Shares |
14-11-2022 | Quarterly Results |
10-08-2022 | Quarterly Results |
30-05-2022 | Audited Results |
14-02-2022 | Quarterly Results |
12-11-2021 | Quarterly Results |
14-08-2021 | Quarterly Results (Revised) |
13-08-2021 | Quarterly Results |
30-06-2021 | Audited Results |